CRESOLUM pellet
Pajjiż: Stati Uniti
Lingwa: Ingliż
Sors: NLM (National Library of Medicine)
Karatteristiċi tal-prodott
(SPC)
13-06-2022
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
CRESOL (UNII: GF3CGH8D7Z) (CRESOL - UNII:GF3CGH8D7Z)
Disponibbli minn:
Hahnemann Laboratories, INC.
Rotta amministrattiva:
ORAL
Tip ta 'preskrizzjoni:
OTC DRUG
L-istatus ta 'awtorizzazzjoni:
unapproved homeopathic
Karatteristiċi tal-prodott
CRESOLUM- CRESOLUM PELLET
HAHNEMANN LABORATORIES, INC.
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug_
_Administration for safety or efficacy. FDA is not aware of scientific
evidence to support_
_homeopathy as effective._
----------
Aqra d-dokument sħiħ
